| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/06/2004 | US6717000 Antidepressants |
| 04/06/2004 | US6716985 Alcoholism, psychological disorders |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716860 Azo amino acids derivatives |
| 04/06/2004 | US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity |
| 04/06/2004 | US6716854 Treatments for restless legs syndrome |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716624 GSK3 polypeptides |
| 04/06/2004 | US6716623 Compositions and methods for identifying antigens which elicit an immune response |
| 04/06/2004 | US6716589 Discordant helix stabilization for prevention of amyloid formation |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | CA2299399C Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/06/2004 | CA2060616C Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 04/01/2004 | WO2004026876A1 Alkyl-substituted pyrazolopyrimidines |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026861A1 Process for producing paroxetine hydrochloride hydrate |
| 04/01/2004 | WO2004026857A2 Methods of purifying cannabinoids from plant material |
| 04/01/2004 | WO2004026850A1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiaoles from cyclohexanes and cyclohexanones as intermediates |
| 04/01/2004 | WO2004026833A1 Cyclic amine compound, process for producing the same, and use |
| 04/01/2004 | WO2004026832A1 Urea compound and use thereof |
| 04/01/2004 | WO2004026830A1 2,7-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | WO2004026827A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026826A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/01/2004 | WO2004026825A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026819A2 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026331A1 Peptides inhibiting specific cleaving activities of presenilins |
| 04/01/2004 | WO2004026314A1 Modified release formulations of oxcarbazepine and derivatives thereof |
| 04/01/2004 | WO2004026308A1 Sustained release compound of acetamidophenol and tramadol |
| 04/01/2004 | WO2004026301A1 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands |
| 04/01/2004 | WO2004026299A1 Treatment of dyskinesia |
| 04/01/2004 | WO2004026296A1 Composition against stress-related diseases |
| 04/01/2004 | WO2004026291A1 Oral formulations of ibuprofen and tramadol, methods and preparation thereof |
| 04/01/2004 | WO2004026286A2 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
| 04/01/2004 | WO2004026229A2 Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors |
| 04/01/2004 | WO2004018482A3 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 04/01/2004 | WO2004017977A3 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004009559A3 Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents |
| 04/01/2004 | WO2004006933A3 Crystal forms of olanzapine and processes for their preparation |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003099256A3 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES) |
| 04/01/2004 | WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function |
| 04/01/2004 | WO2003097633A8 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 04/01/2004 | WO2003089449A3 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 04/01/2004 | WO2003088927A3 Novel curcumin analogues and uses thereof |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 04/01/2004 | WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003079998A3 Treatment of diseases involving defective gap junctional communication |
| 04/01/2004 | WO2003077893A3 Compositions for treating digestive functional pathologies |
| 04/01/2004 | WO2003075932A8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003068148A3 Treatment of sleep disorders using sleep target modulators |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003061654A9 Pramipexole for the treatment of hiv dementia |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | WO2003054226A3 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 04/01/2004 | WO2003049675A3 Treating muscle wasting with selective androgen receptor modulators |
| 04/01/2004 | WO2003048147A3 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003016563A3 Novel molecular target for neurotoxicity |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002089798A3 Method and compositions for treating migraines |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | WO2002070676A9 Use of protein histidine phosphatase |
| 04/01/2004 | WO2002066480A3 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 04/01/2004 | WO2002058637A9 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 04/01/2004 | WO2002043654A8 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 04/01/2004 | US20040063974 Antidepressants; anxiolytic agents; antiinflammatory agents; analgesics; antiemetics |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063946 Jnk inhibitor |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |